Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder

By van Baardewijk M.   Vis P. M. J.   Einarson T. R.  

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder

By Armstrong Edward P.   Malone Daniel C.   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1115-1121

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

By Wade A.   Gembert K.   Florea I.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1605-1614

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A.   Greist John H.   Mallinckrodt Craig H.   Prakash Apurva   Sambunaris Angelo   Tollefson Gary D.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants

By Wu Eric   Greenberg Paul   Yang Elaine   Yu Andrew   Ben-Hamadi Rym   Erder M. Haim  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2805-2813

Informa Healthcare

Access to resources Recommend Favorite